Description
Diaformin SR (Metformin) Tablets with Prolonged Release 500 mg. №60
Composition
Each tablet contains 500 mg of metformin with prolonged release.
Mechanism of Action
Metformin, the active ingredient in Diaformin SR, acts as a first-line medication for the management of type 2 diabetes mellitus. It functions by reducing hepatic glucose production and enhancing insulin sensitivity in the body’s tissues.
Pharmacological Properties
Diaformin SR tablets with prolonged release exhibit hypoglycemic effects by decreasing fasting plasma glucose and improving glycemic control without causing hypoglycemia.
Indications for Use
Diaformin SR tablets are specifically prescribed for the treatment of type 2 diabetes mellitus to help regulate blood sugar levels.
Contraindications
Avoid using Diaformin SR if you have severe kidney impairment or metabolic acidosis. It is crucial to consult a healthcare professional before initiating treatment.
Side Effects
Common side effects of Diaformin SR may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. In rare cases, lactic acidosis can occur, necessitating immediate medical attention.
Usage Instructions
The typical dosage regimen involves taking one tablet of Diaformin SR once daily with a meal. Swallow the tablet whole with a glass of water; do not crush or chew it.
Benefits Compared to Analogues
Diaformin SR with prolonged release offers the advantage of convenient once-daily dosing, ensuring a consistent medication level in the bloodstream over 24 hours. This feature enhances treatment adherence and aids in optimizing glycemic management compared to standard metformin formulations.
Suitable Patient Groups
Diaformin SR is suitable for a wide range of patients, including adults, elderly individuals, and adolescents with type 2 diabetes mellitus. However, individualized dosing adjustments may be necessary based on age and renal function.
Storage and Shelf Life
Store Diaformin SR tablets in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to maintain product integrity. Check the expiration date on the packaging and do not use expired tablets.
Packaging Description
Diaformin SR tablets are typically packaged in blister packs containing 60 tablets per pack. The packaging is designed to protect the tablets from external factors and maintain their stability.
Clinical Evidence and Proven Effectiveness
Metformin, the key component of Diaformin SR, has been extensively studied for its efficacy in managing type 2 diabetes. Clinical studies have demonstrated the effectiveness of metformin in reducing blood glucose levels, improving insulin sensitivity, and lowering the risk of diabetes-related complications.
Additional Information
In addition to its primary indication for diabetes management, metformin has shown promising outcomes in conditions such as polycystic ovary syndrome (PCOS) and potential cancer risk reduction. Consult your healthcare provider for personalized guidance on the usage of Diaformin SR and its potential benefits for your health.
